Renovate Biologicals Private Limited, a active private limited company, was established on 09 July 2015 in Mahabubnagar, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100TG2015PTC099749. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 18 professional, Its leadership includes Munagapati Naveen Kumar (Director), Devesh Kedia (Director), Mudunuru Talupuleswara Rao (Director). Past directors included Devesh Kedia, Mudunuru Talupuleswara Rao, Sadanand Sangisetty. It holds no open charges and ₹4.00 M settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 18-90, Srinivasa Colony, Shadnagar,, Mahabubnagar, Telangana, 509216.
U24100TG2015PTC099749
099749
09 July 2015
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Renovate Biologicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Munagapati Naveen Kumar | Director | 09 Jul 2015 | Current |
| Devesh Kedia | Director | 14 Dec 2019 | Current |
| Mudunuru Talupuleswara Rao | Director | 01 Nov 2019 | Current |
| Kota Vijaykumar | Director | 13 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 18 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 25 Oct 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Renovate Biologicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 4007.37% increase. The company also saw a substantial improvement in profitability, with a 20.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 50.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Renovate Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹4,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2018 | Bank Of India | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Renovate Biologicals has a workforce of 18 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Renovate Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renovate Biologicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 14 Feb 2018 via Charge ID 100156937 with Bank Of India was fully satisfied on 01 Jun 2023. was documented.
Progress on Renovate Biologicals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Renovate Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was documented.
The activity Devesh Kedia was appointed as a Director was appointed as a Director on 14 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Mudunuru Talupuleswara Rao was appointed as a Director was appointed as a Director on 01 Nov 2019 & has been associated with this company since 6 years 30 days . was recorded as a recent event.
Kota Vijaykumar was appointed as a Director was appointed as a Director on 13 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
The CIN of Renovate Biologicals Private Limited is U24100TG2015PTC099749.
Renovate Biologicals Private Limited is headquartered at 18-90, Srinivasa Colony, Shadnagar,, Mahabubnagar, Telangana, 509216.
Renovate Biologicals Private Limited was incorporated on 09 July 2015.
The current directors of Renovate Biologicals Private Limited are
The primary industry of Renovate Biologicals Private Limited is Trade.
Renovate Biologicals Private Limited is unlisted.
The authorized capital of Renovate Biologicals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Renovate Biologicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX